Zhejiang Medicine Co Ltd (600216) — Cash Flow Reinvestment Rate
Zhejiang Medicine Co Ltd (600216) has a Cash Flow Reinvestment Rate of 0.12x as of September 2025, reinvesting CN¥80.03 Million (capex CN¥80.03 Million ) from operating cash flow of CN¥690.77 Million. Explore reinvestment intensity of Zhejiang Medicine Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Medicine Co Ltd Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for Zhejiang Medicine Co Ltd across 27 annual periods. Also explore 600216 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zhejiang Medicine Co Ltd (1998–2025)
Year-by-year capital reinvestment analysis for Zhejiang Medicine Co Ltd. For live market cap and broader valuation context, see Zhejiang Medicine Co Ltd (600216) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | CN¥453.57 Million | CN¥1.89 Billion | CN¥446.47 Million | ▼ -58.8% |
| 2024 | 0.58x | CN¥714.46 Million | CN¥1.22 Billion | CN¥689.14 Million | ▼ -71.8% |
| 2023 | 2.07x | CN¥1.32 Billion | CN¥634.31 Million | CN¥796.87 Million | ▼ -44.6% |
| 2022 | 3.74x | CN¥1.95 Billion | CN¥520.60 Million | CN¥975.99 Million | ▲ +334.4% |
| 2021 | 0.86x | CN¥978.73 Million | CN¥1.14 Billion | CN¥939.60 Million | ▲ +29.5% |
| 2020 | 0.66x | CN¥835.67 Million | CN¥1.26 Billion | CN¥535.35 Million | ▼ -52.8% |
| 2019 | 1.41x | CN¥630.40 Million | CN¥447.25 Million | CN¥573.63 Million | ▲ +79.9% |
| 2018 | 0.78x | CN¥454.26 Million | CN¥579.91 Million | CN¥439.30 Million | ▼ -53.7% |
| 2017 | 1.69x | CN¥851.21 Million | CN¥503.47 Million | CN¥569.99 Million | ▲ +48.8% |
| 2016 | 1.14x | CN¥382.01 Million | CN¥336.14 Million | CN¥381.76 Million | ▼ -87.8% |
| 2015 | 9.29x | CN¥989.93 Million | CN¥106.54 Million | CN¥724.96 Million | ▲ +415.2% |
| 2014 | 1.80x | CN¥991.76 Million | CN¥549.90 Million | CN¥991.76 Million | ▼ -0.5% |
| 2013 | 1.81x | CN¥1.19 Billion | CN¥655.09 Million | CN¥1.19 Billion | ▲ +54.8% |
| 2012 | 1.17x | CN¥945.50 Million | CN¥807.49 Million | CN¥945.50 Million | ▲ +210.2% |
| 2011 | 0.38x | CN¥344.58 Million | CN¥912.75 Million | CN¥344.58 Million | ▲ +240.6% |
| 2010 | 0.11x | CN¥145.90 Million | CN¥1.32 Billion | CN¥145.90 Million | ▲ +6.0% |
| 2009 | 0.10x | CN¥153.13 Million | CN¥1.47 Billion | CN¥153.13 Million | ▼ -3.7% |
| 2008 | 0.11x | CN¥130.27 Million | CN¥1.20 Billion | CN¥130.27 Million | ▼ -83.9% |
| 2007 | 0.67x | CN¥153.37 Million | CN¥227.67 Million | CN¥153.37 Million | ▼ -54.3% |
| 2006 | 1.47x | CN¥249.99 Million | CN¥169.51 Million | CN¥249.99 Million | ▼ -89.2% |
| 2005 | 13.60x | CN¥341.93 Million | CN¥25.14 Million | CN¥341.93 Million | ▲ +910.5% |
| 2004 | 1.35x | CN¥144.80 Million | CN¥107.60 Million | CN¥144.80 Million | ▼ -32.2% |
| 2003 | 1.98x | CN¥131.37 Million | CN¥66.20 Million | CN¥131.37 Million | ▼ -78.5% |
| 2002 | 9.25x | CN¥213.81 Million | CN¥23.13 Million | CN¥213.81 Million | ▲ +654.2% |
| 2001 | 1.23x | CN¥120.44 Million | CN¥98.25 Million | CN¥120.44 Million | ▼ -89.5% |
| 2000 | 11.69x | CN¥123.69 Million | CN¥10.58 Million | CN¥123.69 Million | ▲ +435.0% |
| 1998 | 2.18x | CN¥126.08 Million | CN¥57.72 Million | CN¥126.08 Million | — |